BRIEF-Collegium Announces Authorized Agreement With Hikma Pharmaceuticals USA For Nucynta
Dow Jones Industrial Average DJI | 42924.89 | -0.02% |
Collegium Pharmaceutical, Inc. COLL | 36.19 | -0.74% |
S&P 500 index SPX | 5851.20 | -0.05% |
NASDAQ IXIC | 18573.13 | +0.18% |
April 29 (Reuters) - Collegium Pharmaceutical Inc COLL.O:
COLLEGIUM ANNOUNCES AUTHORIZED GENERIC AGREEMENT WITH HIKMA PHARMACEUTICALS USA INC. FOR NUCYNTA® AND NUCYNTA® ER
COLLEGIUM: HIKMA WILL HAVE EXCLUSIVE RIGHT TO SELL AUTHORIZED GENERIC VERSIONS OF NUCYNTA & NUCYNTA ER IN U.S.
Source text for Eikon: ID:nGNX7yGX8W
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))